Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo. - Wikidata - wikimedia - TriplyDB

Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

http://www.wikidata.org/entity/Q37616428

about

Ubiquitin-dependent regulation of Foxp3 and Treg function Regulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantation The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses Effective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer.Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/- Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice.Regulatory T cells in retroviral infections.The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells.Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.

P2860

Q26863525-E9ED7F60-0D12-4054-9810-A2321C972E88 Q34454926-C39B4D5F-207E-4BB9-9B32-EC94FCE10D52 Q36940326-A61D467E-7BBD-4FA0-9B02-2404FBB4ACC3 Q37459043-EBACB738-802E-445B-9303-3AD0961C6F0A Q49438074-19142E2D-3A69-4743-AAFB-8DD4EFD67C40 Q49979151-A4EADFE7-93FA-47A2-8363-30895711D5C0 Q52330488-13C699AB-3696-4F5A-B2A3-38D3D361EE6D Q55007606-67EAE822-F9FA-447B-9C3F-8B07FDB590F5

P2860

Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.

http://www.wikidata.org/entity/Q37616428

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@en

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@nl

type

label

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@en

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@nl

prefLabel

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@en

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@nl

P1433

Q37616428-BF651067-DA4B-49F9-87AC-20AAC71BB309

P1476

Q37616428-7C89FB60-EAD1-4A92-9FEC-0255516F3385

P2093

Q37616428-4E7B26FA-82E1-42E0-8C6B-5C1A3E9E63F3

Q37616428-5773EDD3-0995-4E33-8A4A-1CA40AD1D842

Q37616428-62306D11-C970-42E1-BDD8-B47328878D77

Q37616428-726D29AE-B390-4A7A-A6F7-7904018ABADA

Q37616428-975B3F0E-F65D-4C08-8A83-516EBDC71754

Q37616428-C0215BAF-1571-42AE-BBB4-D4D7080A3858

P2860

Q37616428-01F7C210-6656-487E-A9D8-6118E5362943

Q37616428-10D2DFCC-E0B7-41B0-B9AD-FEF01B7BCF63

Q37616428-14AEB127-6DED-41D0-AFC1-B87118E5EB5C

Q37616428-175DDC58-0795-4A26-B965-5977F00EF14A

Q37616428-18F73C8A-BEB6-4ED7-9B07-996C6EC2CCE6

Q37616428-19A41AA4-DA72-46AF-BAAB-23B6CA963B87

Q37616428-1ACC0EFE-E353-4EDC-949C-66C91D2EE728

Q37616428-26F9C53D-51FF-4715-9F19-31724EF695A7

Q37616428-27775641-1C3C-4E66-951C-F60F6A3A3727

Q37616428-32FCFE9C-A1E4-45AF-9975-0218356AFEED

P304

Q37616428-50B57258-4B2F-456C-90A0-F62140503022

P31

Q37616428-C1C37F93-ADB8-4B93-96CB-0483C11C8EEE

P356

Q37616428-32F591C7-E1E2-45E5-8A04-3306B9958532

P433

Q37616428-35D37569-5B23-4731-97DC-DA2E06365A59

P478

Q37616428-6F4BD714-3FA6-45A5-AF73-0AD62C0FB07E

P50

Q37616428-6DF0D38C-13FB-4C56-B607-B704646BE713

P577

Q37616428-83702555-8964-49E7-8192-AE933C48F59B

P698

Q37616428-C9B81327-15B6-4B97-8279-57A8AEF9EA9A

P932

Q37616428-CBD004A9-E47B-4F5E-90ED-6547270907AC

P356

J.CLIM.2013.08.007

P1433

Clinical Immunology

P1476

Therapeutic polyclonal human C ...... ulatory cells induced ex-vivo.

@en

P2093

David A Horwitz

http://www.w3.org/2001/XMLSchema#string

J Dixon Gray

http://www.w3.org/2001/XMLSchema#string

Jing-Ni Ou

http://www.w3.org/2001/XMLSchema#string

Maogen Chen

http://www.w3.org/2001/XMLSchema#string

Song Guo Zheng

http://www.w3.org/2001/XMLSchema#string

Stephanie Pan

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells

T cell exhaustion

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.

Treating human autoimmunity: current practice and future prospects

Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid

Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

Generation and regulation of CD8(+) regulatory T cells.

P304

450-463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLIM.2013.08.007

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24211847

http://www.w3.org/2001/XMLSchema#string

P932

3941976

http://www.w3.org/2001/XMLSchema#string